Loading insider details...
Latest Form 4 (May 13, 2026): Grant/Award of 50,000 ATYR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 13, 2026 | aTYR PHARMA INC (ATYR) | Grant/Award | 50,000 | n/a |
| May 2, 2025 | aTYR PHARMA INC (ATYR) | Grant/Award | 50,000 | n/a |
| Mar 17, 2025 | aTYR PHARMA INC (ATYR) | Purchase | 3,750 | $15.0K |
| May 23, 2024 | aTYR PHARMA INC (LIFE) | Grant/Award | 24,000 | n/a |
| May 19, 2023 | aTYR PHARMA INC (LIFE) | Grant/Award | 12,000 | n/a |
| Apr 28, 2023 | aTYR PHARMA INC (LIFE) | Exercise/Conversion | 6,000 | n/a |
| Apr 28, 2022 | aTYR PHARMA INC (LIFE) | Grant/Award | 6,000 | n/a |
| Apr 30, 2021 | aTYR PHARMA INC (LIFE) | Grant/Award | 1,428 | n/a |
| Feb 18, 2021 | Aptevo Therapeutics Inc. (APVO) | Grant/Award | 16,500 | n/a |
| Jul 31, 2020 | Aptevo Therapeutics Inc. (APVO) | Disposition to Issuer | 2,072 | n/a |